Category: Joint ventures/collaborations
-
Biotechs Apply Crispr Gene-Editing for Hemophilia
A treatment for the blood disease hemophilia and other inherited disorders are being developed with the gene-editing technology Crispr in a biotechnology deal.
-
Covid-19 Antibody Therapy Trial Underway
A clinical trial of neutralizing antibodies to treat Covid-19 infections began testing the therapy with hospitalized patients in New York and Los Angeles.
-
Drug Added to Covid-19 Lung Disease Trial
A clinical trial evaluating numerous therapies for a serious lung complication of Covid-19 infections is adding a drug to treat glaucoma to the study.
-
Drug Maker Licenses Low-Dose Vaccine Patch
The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes.
-
Merck Inks Three Covid-19 Vaccine, Therapy Deals
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections.
-
Covid-19 Therapies Designed with Virtual Reality, A.I.
Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed.
-
GSK, Biotech Partner on Crispr Covid-19 Test
A biotechnology company using gene editing for diagnostics is developing a fast, point-of-care Covid-19 test with drug maker GlaxoSmithKline.
-
Venture Producing Covid-19 Antibody Test Kits
A new company formed from a medical research lab is producing test kits for detecting and measuring a person’s Covid-19 antibodies.
-
FDA Analyzing Real-World Evidence on Covid-19
The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic.
-
Antibody Neutralizes Covid-19, SARS Viruses
An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections.